Abstract
A patient had cutaneous protothecosis because of the alga like organism, Prototheca wickerhamii. In vitro sensitivity tests showed that the organism was sensitive to amphotericin B, and the patient was treated successfully with this polyene antibiotic. As with treatment of some fungal infections, a clinical response was achieved when therapy with low doses of amphotericin B was given during a short period of time. The basis of the amphotericin B response may have been due to a combination of its immunostimulatory and antibiotic properties.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1749-1752 |
| Number of pages | 4 |
| Journal | Archives of Dermatology |
| Volume | 112 |
| Issue number | 12 |
| DOIs | |
| State | Published - 1976 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Cutaneous protothecosis. Successful treatment with amphotericin B. / Mayhall, C. G.; Miller, C. W.; Eisen, A. Z.; Kobayashi, G. S.; Medoff, G.
In: Archives of Dermatology, Vol. 112, No. 12, 1976, p. 1749-1752.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cutaneous protothecosis. Successful treatment with amphotericin B
AU - Mayhall, C. G.
AU - Miller, C. W.
AU - Eisen, A. Z.
AU - Kobayashi, G. S.
AU - Medoff, G.
PY - 1976
Y1 - 1976
N2 - A patient had cutaneous protothecosis because of the alga like organism, Prototheca wickerhamii. In vitro sensitivity tests showed that the organism was sensitive to amphotericin B, and the patient was treated successfully with this polyene antibiotic. As with treatment of some fungal infections, a clinical response was achieved when therapy with low doses of amphotericin B was given during a short period of time. The basis of the amphotericin B response may have been due to a combination of its immunostimulatory and antibiotic properties.
AB - A patient had cutaneous protothecosis because of the alga like organism, Prototheca wickerhamii. In vitro sensitivity tests showed that the organism was sensitive to amphotericin B, and the patient was treated successfully with this polyene antibiotic. As with treatment of some fungal infections, a clinical response was achieved when therapy with low doses of amphotericin B was given during a short period of time. The basis of the amphotericin B response may have been due to a combination of its immunostimulatory and antibiotic properties.
UR - http://www.scopus.com/inward/record.url?scp=0017050289&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017050289&partnerID=8YFLogxK
U2 - 10.1001/archderm.112.12.1749
DO - 10.1001/archderm.112.12.1749
M3 - Article
C2 - 1008567
AN - SCOPUS:0017050289
VL - 112
SP - 1749
EP - 1752
JO - JAMA Dermatology
JF - JAMA Dermatology
SN - 2168-6068
IS - 12
ER -